Clinical Trial Update: Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating temozolomide for preventing brain metastases in small cell lung cancer is reported as ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma
• Small Cell Lung Cancer

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Guangzhou Medical University | Conditions: Small Cell Lung Cancer, Metastatic Carcinoma | Phase 2 | Status: UNKNOWN